RTW INVESTMENTS, LP - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 87 filers reported holding PROTAGONIST THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
RTW INVESTMENTS, LP ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$90,330,774
-39.6%
5,415,5140.0%1.91%
-33.1%
Q2 2023$149,576,497
+41.4%
5,415,514
+17.7%
2.85%
+29.2%
Q1 2023$105,818,377
+170.0%
4,600,799
+28.1%
2.20%
+175.5%
Q4 2022$39,188,567
+11.3%
3,591,986
-14.0%
0.80%
-1.5%
Q3 2022$35,211,000
-7.2%
4,176,837
-12.9%
0.81%
-17.1%
Q2 2022$37,924,000
-66.6%
4,794,4990.0%0.98%
-58.3%
Q1 2022$113,534,000
+27.7%
4,794,499
+84.4%
2.35%
+81.0%
Q4 2021$88,914,000
+186.1%
2,599,822
+48.2%
1.30%
+176.8%
Q3 2021$31,075,000
-80.3%
1,753,695
-50.0%
0.47%
-80.3%
Q2 2021$157,412,000
+73.3%
3,507,3900.0%2.38%
+67.5%
Q1 2021$90,841,000
+23.5%
3,507,390
-3.9%
1.42%
+14.8%
Q4 2020$73,585,000
+10.4%
3,650,069
+7.1%
1.24%
-23.1%
Q3 2020$66,645,000
+11.5%
3,408,961
+0.8%
1.60%
-4.5%
Q2 2020$59,747,000
+218.1%
3,383,208
+27.2%
1.68%
+108.0%
Q1 2020$18,782,000
+8.3%
2,660,392
+8.1%
0.81%
+23.5%
Q4 2019$17,343,000
+89.4%
2,459,988
+222.7%
0.65%
+20.2%
Q3 2019$9,155,000762,2830.54%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 2,449,183$43,400,0003.81%
BVF INC/IL 3,901,759$69,139,0002.70%
COMMODORE CAPITAL LP 498,079$8,826,0002.33%
Altium Capital Management LP 346,000$6,131,0001.61%
Twin Lakes Capital Management, LLC 139,287$2,468,0001.45%
Opaleye Management Inc. 330,222$5,852,0001.09%
EcoR1 Capital, LLC 1,443,800$25,584,0000.89%
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP 776,689$13,763,0000.76%
JABODON PT CO 90,656$1,606,0000.66%
Artal Group S.A. 1,500,000$26,580,0000.60%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders